Treatment of postmenopausal osteoporosis with salmon calcitonin suppositories

Italian Journal of Mineral and Electrolyte Metabolism

Volumn 10, Issue 1, 1996, Pages 23-28

  Mazzantini, M ^a   Di Munno, O ^a   Pardini, N ^a   Ferdeghini, M ^a   Mandolesi, M C ^a   Nasti, P ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

bone mineral density; calcium; osteoporosis; postmenopausal; Salmon calcitonin

Indexed keywords

CALCIUM; SALCATONIN;

ADULT; AGED; ARTICLE; BONE MASS; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SUPPOSITORY;

EID: 0030055880     PISSN: 11211709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lucht Y. Effects of calcitonin on osteoclast in vivo. An ultrastructural and histochemical study. Z Zellforsch 1973;145:75-87.
2. Avioli LV. The benefits of long term calcitonin treatment in Paget's disease of bone. In: Pecile A, editor. Calcitonin. Amsterdam: Elsevier 1984:325.
3. De Rose J, Singer FR. Response of Paget's disease to porcine and salmon calcitonin: effects of long term treatment. Am J Med 1974;56:858.
4. Kanis JA, Horn DB, Scott RDM, Strong JA. Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br J Med 1974;3:727.
5. Bijvoet OLM, Van der Sluys Veer J, Jansen AP. Effects of calcitonin on patient with Paget's disease, thyrotoxicosis of hypercalcemia. Lancet 1968;1:876-81.
6. Gennari C. Calcitonin and bone metastases of cancer. In: Pecile A, editor. Calcitonin 1980. Amsterdam: Excerpta Medica, 1981:277-87.
7. Dowry P, Dirheimer Y, Pattin S. Algodystrophy. New York: Springer-Verlag 1981.
8. Mazzuoli GF, Passeri M, Gennari C, et al. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double blind clinical study. Calcif Tissue Int 1986;38:3-8.
9. Gennari C, Chierichetti SM, Bigazzi S et al. Comparative effects on bone mineral content of calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis. Curr Ther Res 1985;38:455-8.
10. Overgaard K, Riis BJ, Christiansen C, et al. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 1989;30:435-42.
11. Reginster JY, Albert A, Franchimont P. Salmon calcitonin nasal spray in Paget's disease of bone: preliminary result in five patients. Calcif Tissue Int 1985;37:557-62.
12. Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effects of salcatonin given intranasally on early postmenopausal bone loss. Br Med J 1989;299:477-9.
13. Raz I, Bar-On H, Kidron M, Ziv E. Rectal administration of insulin. Isr J Med Sci 1984;20:173-5.
14. Yamasaki Y, Schichiri M, Kawamori R, et al. The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects. Diabetes Care 1981;4:454.
15. Buclin T, Randin JP, Jacquet AF, et al. The effect of rectal and nasal administration of salmon calcitonin in normal subjects. Calcif Tissue Int 1987;41:252-8.
16. Thiébaud D, Burckhardt P, Jaeger P, Azria M. Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia. Am J Med 1987;82-745.
17. Nagant de Deuxchaisnes C, Devogelear JP, Huaux JP, et al. New modes of administration of salmon calcitonin in Paget's disease. Clin Orthop 1987;217:56-71.
18. Overgaard K, Hansen MA, Dirksen KL, Christiansen C. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis. Calcif Tissue Int 1992;51:184-8.
19. Kollerup G, Hermann AP, Brixen K, Lindblad BE, Mosekilde L, Sørensen OH. Effects of salmon calcitonin suppositories on hone mass and turnover in established osteoporosis. Calcif Tissue Inter 1994;54:12-5.